96 Recruiting Advanced Malignant Solid Neoplasm Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Advanced Malignant Solid Neoplasm
Related Conditions
Top Recruiting Advanced Malignant Solid Neoplasm Studies
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study
📍 UT MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Technology-Enhanced Palliative Care for Advanced Cancer Patients
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Learning Collaborative Versus Technical Assistance in Delivering a Palliative Care Program to Patients With Advanced Cancer and Their Caregivers
📍 Mercy Hospital Fort Smith — Fort Smith, Arkansas
View Study & Checklist ➔Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
📍 Cancer Center at Saint Joseph's — Phoenix, Arizona
View Study & Checklist ➔Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Patient Considerations of Social Media Account Management After Death
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
📍 Arizona Center for Cancer Care - Gilbert — Gilbert, Arizona
View Study & Checklist ➔Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected Mutations
📍 Keck Medicine of USC Buena Park — Buena Park, California
View Study & Checklist ➔Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
View Study & Checklist ➔FID-007 in Treating Participants With Advanced Solid Tumors
📍 Los Angeles General Medical Center — Los Angeles, California
View Study & Checklist ➔Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
📍 Children's Hospital of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
📍 UC Irvine Health Cancer Center-Newport — Costa Mesa, California
View Study & Checklist ➔Adoption of Audio Recording in the Outpatient Supportive Care Center
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person
📍 Providence Regional Cancer Partnership — Everett, Washington
View Study & Checklist ➔Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔